GANA X

The benefits of GANA X are:
- Improves elasticity, firmness and skin tone.
- It corrects depressions and loss of thickness gradually.
- Progressive and long-lasting effect.
- Suitable for major volumetric corrections for more noticeable results.
- Natural and customisable results.

- GANA R&D CO., LTD.
- NAME: GANA X
- COMPOSITION: Poly-L-lactic acid 630 mg, CMC (carboxymethylcellulose sodium), Mannitol (medical grade).
- PRESENTATION: 1 x 630mg/40 ml.
- INDICATIONS: A device designed to increase volume and firm up depressed areas of the body, particularly the buttocks, hips and chest, and the face by stimulating natural collagen production.
- APPLICATION: Deep dermis or subcutaneous layer.
- DURATION: It is suggested that the second session be performed 30 days after the first, and the third session 30 days after the second. The minimum frequency between application sessions is 1 month.
After the third session, the minimum recommended frequency for subsequent treatments is between 6 and 12 months. Three or more sessions are permitted, depending on the doctor's assessment.
- USE: Strict medical use.

- Vial: 1 x 630mg/40 ml.

Temporal area, nasolabial folds, zygomatic area and cheeks, buttocks, arms, inner thighs, knees and areas of the body with significant emptying.

Poly-L-lactic acid 630 mg, CMC (sodium carboxymethyl cellulose), Mannitol (medical grade).

- This product should only be used by a physician who is fully familiar with the product, the related educational material and the entire patient information leaflet and labelling.
- The treatment area must be cleaned with an antiseptic and must be free of inflammation or infection.
- As with all injections, patients with coagulation disorders or on concomitant anticoagulant therapy have an increased risk of haematoma, ecchymosis and/or bleeding at the injection site.
- The safety and efficacy of this product have not been evaluated in patients who are pregnant, lactating or under the age of 18.
- No studies have been conducted on the interactions of this product with drugs, other substances or implants.
- An increased risk of papules and nodules after injections in the periorbital area has been reported in the literature.
- The safety and efficacy of the product have not been evaluated in patients predisposed to keloid or hypertrophic scar formation. Therefore, it should not be used in patients with a known history or susceptibility to keloid or hypertrophic scar formation.
- The patient should be instructed to limit exposure of the treated area to the sun and avoid exposure to UV lamps until any initial oedema and redness has completely resolved.

- This product must not be used in persons with active inflammation or infection in or adjacent to the treatment area.
- This product must not be used in persons with hypersensitivity to any of its components.
- Do not use in or near the periorbital area and lips.
- Do not use around the eyes.

The device is indicated for increasing the volume of depressed areas and for major volumetric corrections in the facial region, including: temporal area, nasolabial folds, zygomatic area and cheeks, and for increasing the volume of depressed areas, such as buttocks, arms, inner thighs, knees and areas of the body with major depletion.